These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 25615881

  • 1. The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family.
    Hoppentocht M, Akkerman OW, Hagedoorn P, Frijlink HW, de Boer AH.
    Eur J Pharm Biopharm; 2015 Feb; 90():8-15. PubMed ID: 25615881
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs.
    Miller DP, Tan T, Tarara TE, Nakamura J, Malcolmson RJ, Weers JG.
    Mol Pharm; 2015 Aug 03; 12(8):2582-93. PubMed ID: 26052676
    [Abstract] [Full Text] [Related]

  • 4. Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.
    de Boer AH, Hagedoorn P, Westerman EM, Le Brun PP, Heijerman HG, Frijlink HW.
    Eur J Pharm Sci; 2006 Jun 03; 28(3):171-8. PubMed ID: 16650739
    [Abstract] [Full Text] [Related]

  • 5. Spray-dried carrier-free dry powder tobramycin formulations with improved dispersion properties.
    Pilcer G, Vanderbist F, Amighi K.
    J Pharm Sci; 2009 Apr 03; 98(4):1463-75. PubMed ID: 18752304
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of spray-dried tobramycin powders containing nanoparticles for pulmonary delivery.
    Pilcer G, Vanderbist F, Amighi K.
    Int J Pharm; 2009 Jan 05; 365(1-2):162-9. PubMed ID: 18782609
    [Abstract] [Full Text] [Related]

  • 7. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Pharm Sci; 2014 Sep 05; 103(9):2937-2949. PubMed ID: 24740732
    [Abstract] [Full Text] [Related]

  • 8. Low powder mass filling of dry powder inhalation formulations.
    Eskandar F, Lejeune M, Edge S.
    Drug Dev Ind Pharm; 2011 Jan 05; 37(1):24-32. PubMed ID: 20738180
    [Abstract] [Full Text] [Related]

  • 9. Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation.
    Cuvelier B, Eloy P, Loira-Pastoriza C, Ucakar B, Sanogo AA, Dupont-Gillain C, Vanbever R.
    Int J Pharm; 2015 Nov 30; 495(2):981-90. PubMed ID: 26456267
    [Abstract] [Full Text] [Related]

  • 10. Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product construction.
    Belotti S, Rossi A, Colombo P, Bettini R, Rekkas D, Politis S, Colombo G, Balducci AG, Buttini F.
    Int J Pharm; 2014 Aug 25; 471(1-2):507-15. PubMed ID: 24886692
    [Abstract] [Full Text] [Related]

  • 11. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H, Teo J, Chew JW, Hadinoto K.
    Int J Pharm; 2016 Feb 29; 499(1-2):38-46. PubMed ID: 26757148
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW, Li X, Vogt FG, Hayes D, Zwischenberger JB, Park ES, Mansour HM.
    Int J Pharm; 2013 Oct 15; 455(1-2):374-92. PubMed ID: 23820131
    [Abstract] [Full Text] [Related]

  • 14. Carrier-free combination for dry powder inhalation of antibiotics in the treatment of lung infections in cystic fibrosis.
    Pilcer G, De Bueger V, Traina K, Traore H, Sebti T, Vanderbist F, Amighi K.
    Int J Pharm; 2013 Jul 15; 451(1-2):112-20. PubMed ID: 23643509
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Computational fluid dynamics (CFD) assisted performance evaluation of the Twincer™ disposable high-dose dry powder inhaler.
    de Boer AH, Hagedoorn P, Woolhouse R, Wynn E.
    J Pharm Pharmacol; 2012 Sep 15; 64(9):1316-25. PubMed ID: 22881443
    [Abstract] [Full Text] [Related]

  • 17. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
    Weers JG, Miller DP, Tarara TE.
    AAPS PharmSciTech; 2019 Feb 07; 20(3):103. PubMed ID: 30734187
    [Abstract] [Full Text] [Related]

  • 18. The Delivery of High-Dose Dry Powder Antibiotics by a Low-Cost Generic Inhaler.
    Parumasivam T, Leung SS, Tang P, Mauro C, Britton W, Chan HK.
    AAPS J; 2017 Jan 07; 19(1):191-202. PubMed ID: 27679516
    [Abstract] [Full Text] [Related]

  • 19. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
    Eedara BB, Tucker IG, Das SC.
    Int J Pharm; 2016 Jun 15; 506(1-2):174-83. PubMed ID: 27091294
    [Abstract] [Full Text] [Related]

  • 20. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.
    Nolan LM, Li J, Tajber L, Corrigan OI, Healy AM.
    Int J Pharm; 2011 Feb 28; 405(1-2):36-46. PubMed ID: 21129460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.